⚕️FREE MSRA PODCAST –Pharyngeal Pouch (Zenker’s Diverticulum)

🎧 A clear, high-yield breakdown of this rare but classic structural throatdisorder – perfect for exam prep andreal-life clinical scenarios.

🧠Key Learning Points

📌Definition

• Pharyngeal pouch(Zenker’s Diverticulum) is a posterioroutpouching of the pharyngeal mucosa.

• It typically formsat a weak spot in the pharyngeal wallcalled Killian’s dehiscence, between the thyropharyngeus and cricopharyngeus muscles.

📌Causes & RiskFactors

• Main cause: Cricopharyngeal muscle dysfunction leading to increased intraluminal pressure duringswallowing.

• Key risk factors:

 – Age >70 years

 – Male sex (5:1 male:female ratio)

 – Neuromuscular disorders affecting swallowingcoordination

 – Chronic pharyngeal inflammation

• Exact mechanismnot fully understood – thought to be due to uncoordinatedswallowing mechanics.

📌Pathophysiology

• Increased pressure during swallowing → mucosaherniates through Killian’s dehiscence.

• Results in a pouch that traps food and secretions.

• Leads to progressive dysphagia, regurgitation, and potential aspiration.

📌Symptoms

• Dysphagia (difficulty swallowing)

• Regurgitation of undigested food – sometimeshours after eating

• Chronic cough, especially after eating ordrinking

• Halitosis (bad breath) from food retention anddecay

• Gurgling neck swelling on palpation

• Aspiration episodes → recurrent chestinfections

• Sensation of a lump in the throat

📌DifferentialDiagnosis

• Oesophagealstricture (e.g. webs, rings)

• Oesophagealcarcinoma

• Achalasia

• Neurologicaldisorders (e.g. stroke, Parkinson’s)

• Other diverticulaor oropharyngeal masses

📌Diagnosis

• Barium swallow study – gold standard

 – Reveals size,shape, and dynamics of the pouch

• Videofluoroscopy – dynamic assessment ofswallowing

• Endoscopy – avoided initially due to risk of perforation, but can later help assessthe anatomy

• Indirect laryngoscopy – may show saliva pooling in the piriform fossa

📌Management

1. Conservative (for small/asymptomatic pouches)
    – Dietary changes (soft food, chew thoroughly)
    – Swallowing therapy
2. Surgical (for symptomatic or large pouches)
    – Diverticulectomy ± Cricopharyngeal myotomy
    – Endoscopic stapling (minimally invasive)
    – Dohlman’s procedure – divides septum to allow drainage

• Choice depends on pouch size, patient fitness, andrecurrence risk

📌Complications

• Aspiration pneumonia – from regurgitated foodentering the lungs

• Recurrent chest infections

• Malnutrition – due to feeding difficulty

• Rare: Squamous cell carcinoma developing inlong-standing pouch (debated)

• Surgical risks:nerve damage (voice changes), fistula, mediastinitis

📌Prognosis

• Generally good with appropriate management

• Most patientsexperience significant symptom reliefafter surgery

• Small recurrencerisk with endoscopic techniques

• Untreated casesrisk aspiration and potential respiratorycomplications

📎More MSRA Resourcesfor Pharyngeal Pouch

📝 Revision Notes:

https://www.passthemsra.com/topic/pharyngeal-pouch-revision-notes/

🧠 Flashcards:

https://www.passthemsra.com/topic/pharyngeal-pouch-flashcards/

💬 Accordion Q&A Notes:

https://www.passthemsra.com/topic/pharyngeal-pouch-accordion-qa-notes-2/

🚀 Rapid Quiz:

https://www.passthemsra.com/topic/pharyngeal-pouch-rapid-quiz-2/

🎓 Full Course:

https://www.passthemsra.com/courses/gastroenterology-for-the-msra/

#MSRA #MSRARevision#MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQandANotes#MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision#MSRARevisionWebsite #PharyngealPouch

⚕️FREE MSRA PODCAST –Peutz-Jeghers Syndrome

🎧 A clear, high-yield breakdown of this rare genetic condition with GIpolyps and pigmentation – perfect forexam prep and real-life clinical scenarios.

🧠Key Learning Points

📌Definition

• Peutz-JeghersSyndrome (PJS) is a rare, autosomal dominant inherited disorder.

• It ischaracterised by hamartomatous polyps in the gastrointestinal tract anddistinctive mucocutaneous pigmentation (e.g. lips, mouth, hands, feet).

📌Causes & Genetics

• Caused bymutations in the STK11 (also known as LKB1)gene.

• This generegulates cell growth – when faulty, it leads to polyp formation and increasedcancer risk.

🧠Mnemonic:

STK11 = “StopThe growth of Kancers” (STK) – helps recall tumour suppressor function.

• Inheritancepattern is autosomal dominant:

 – 50% chance ofinheritance if one parent is affected.

 – One copy of themutation is enough to cause the syndrome.

📌Pathophysiology

• STK11 mutationdisrupts normal cell regulation → overgrowth of disorganised but benign tissue(hamartomatous polyps).

• Polyps formanywhere in the GI tract, most commonly in the small intestine.

• These polyps cancause mechanical issues (obstruction, intussusception), bleeding, andcontribute to cancer development over time.

📌Symptoms

• Abdominal pain –often due to bowel obstruction or intussusception

• Gastrointestinalbleeding – may present as anaemia or melaena

• Mucocutaneous pigmentation – dark spots on:

 – Lips

 – Buccal mucosa

 – Hands and feet

• Polyp-relatedsymptoms (pain, bleeding, obstruction)

📌DifferentialDiagnosis

• Familialadenomatous polyposis (FAP)

• Juvenile polyposissyndrome

• Hereditary mixedpolyposis syndrome

• Cowden syndrome

📌Epidemiology

• Rare disorder:estimated incidence ranges from 1 in 25,000 to 1in 300,000

• Equal incidenceacross sexes

• Often diagnosed inchildhood or adolescence due to pigmentation or early-onset GI symptoms

📌Diagnosis

• Clinical features:

 – Mucocutaneouspigmentation

 – Multiple GIpolyps

 – Positive familyhistory

• Definitive test:

 – Genetic testing for STK11 mutation

• Imaging & endoscopy:

 – Upper GIendoscopy and colonoscopy

 – Capsule endoscopyor enteroscopy may be used to evaluate the small bowel

📌Management

1. Surveillance
   • Lifelong endoscopic surveillance (upper and lower)
   • Start in childhood/adolescence
   • Regular imaging and tumour markers based on cancer risk profile
2. Polyp Management
   • Endoscopic removal of large or symptomatic polyps
   • Surgical resection if obstruction or complications arise
3. Cancer Screening & Risk Reduction
   • Screen for GI cancers: bowel, pancreas, stomach
   • Also screen for breast, ovarian, cervical, and testicular cancer
   • Consider early referral to a genetic specialist for family counselling

📌Complications

• Cancer – ~50% lifetime risk of GI malignanciesby age 60

• Intussusceptionand bowel obstruction

• Chronic GIbleeding → iron-deficiency anaemia

• Psychologicalburden from surveillance and cancer risk

📌Prognosis

• Highly dependent on regular surveillance andearly intervention

• With proactive care, outcomes are much improved

• Without monitoring, risk of serious complications including malignancy is significantlyhigher

📎More MSRA Resources for Peutz-Jeghers Syndrome

📝 Revision Notes:https://www.passthemsra.com/topic/peutz-jeghers-syndrome-revision-notes/

🧠 Flashcards:https://www.passthemsra.com/topic/peutz-jeghers-syndrome-flashcards-2/

💬 Accordion Q&A Notes:https://www.passthemsra.com/topic/peutz-jeghers-syndrome-accordion-qa-notes-2/

🚀 Rapid Quiz:https://www.passthemsra.com/topic/peutz-jeghers-syndrome-rapid-quiz-2/

🎓 Full Course:https://www.passthemsra.com/courses/gastroenterology-for-the-msra/

Hashtags #MSRA #MSRARevision#PeutzJeghersSyndrome #STK11 #MSRAFlashcards #GastroMSRA #HamartomatousPolyps#CancerSurveillance #RareDiseases #NICEGuidelines #MSRAExam #MSRARevisionWebsite

🎧FREE MSRA PODCAST –Pancreatitis: Causes, Diagnosis & Management

This high-yieldepisode breaks down everything you need to know about pancreatitis — acute and chronic — including red flags,investigations, treatment, and memory aids.

🧠Key Learning Points

📌Definition

• Pancreatitis is inflammation of the pancreas and can be acute (sudden onset) or chronic (progressive and lasting damage).

• The pancreas isvital for digestive enzyme production andinsulin secretion.

📌Causes & RiskFactors

• Common causes:

 – Gallstones

 – Alcohol misuse

 –Hypertriglyceridaemia

 – Certainmedications

 – Trauma

 – Autoimmuneconditions

 – Infections

 – Genetic disorders(e.g. cystic fibrosis)

• Mnemonic: I GET SMASHED

 I – Idiopathic

 G – Gallstones

 E – Ethanol(alcohol)

 T – Trauma

 S – Steroids

 M – Mumps

 A – Autoimmune

 S – Scorpion sting

 H – Hyperlipidaemia/ Hypercalcaemia

 E – ERCP

 D – Drugs

• Major riskfactors:

 – Alcohol use

 – Gallstones

 – Smoking

 – Obesity

 – Hightriglycerides

 – Family history

📌Pathophysiology

• Premature activation of digestive enzymeswithin the pancreas leads to self-digestion.

• This causes inflammation, necrosis, and potential systemic complications.

📌Clinical Features –Acute Pancreatitis

• Severe epigastric pain, radiating to the back

• Nausea, vomiting,fever, tachycardia

• Abdominaltenderness ± guarding

• May show signs of jaundice if biliary in origin

• Classic signs:

 – Cullen’s sign (periumbilical bruising)

 – Grey-Turner’s sign (flank bruising)

📌DifferentialDiagnosis

• Peptic ulcerdisease

• Biliary colic /cholecystitis

• GI cancers

• Gastroenteritis

• Myocardialinfarction (rarely)

📌Epidemiology (UK)

• 15–30 cases per100,000 per year

• Affects allgenders; more common in middle-aged to olderadults

📌Diagnosis

✅Two of the followingthree:

1. Characteristic symptoms (epigastric pain)
2. Elevated lipase/amylase >3x upper limit (lipase preferred)
3. Imaging findings (CT or ultrasound)

• Ultrasound: Useful for identifying gallstones

• CT abdomen with contrast: For complications

• MRCP / EUS: For detailed ductal imaging incomplex/chronic cases

📌Management – AcutePancreatitis

• Hospital admission

• Aggressive IV fluid resuscitation

• Analgesia – often opioids

• Nutritional support:

 – Oral intakeresumed as tolerated

 – NJ tube feedingif needed

• Blood glucose monitoring

• Antibiotics only if infection suspected

• Address underlyingcause (e.g. cholecystectomy if gallstones)

📌Complications – Acute

• Necrosis, abscess,pseudocyst

• ARDS, shock,renal failure

• DIC, systemic inflammatory response

📌Management – ChronicPancreatitis

• Pain management

• Pancreatic enzyme replacement therapy (PERT)

• Monitor for diabetes

• Nutritionalsupport ± vitamin supplementation

• Complete alcohol and smoking cessation

•Endoscopic/surgical intervention for strictures or pseudocysts

📌Complications –Chronic

• Exocrine insufficiency → steatorrhoea,malabsorption

• Endocrine insufficiency → diabetes mellitus

• Increased risk of pancreatic cancer

📌Prognosis

• Mild acute pancreatitis: Often resolves withsupportive care

• Severe acute pancreatitis: Higher mortality,especially with necrosis

• Chronic pancreatitis: Progressive; long-termimpact on quality of life and nutrition

📎More MSRA Resourcesfor Pancreatitis

📝 Revision Notes:

https://www.passthemsra.com/topic/pancreatitis-revision-notes/

🧠 Flashcards:

https://www.passthemsra.com/topic/pancreatitis-flashcards/

💬 Accordion Q&A Notes:

https://www.passthemsra.com/topic/pancreatitis-accordion-qa-notes/

🚀 Rapid Quiz:

https://www.passthemsra.com/topic/pancreatitis-rapid-quiz/

🎓 Full Course:

https://www.passthemsra.com/courses/gastroenterology-for-the-msra/

#MSRA #MSRARevision#MSRAFlashcards #MSRAQandANotes #MSRAQuiz #MSRATextbook #Pancreatitis#AcutePancreatitis #ChronicPancreatitis #GastroMSRA #NICEGuidelines#PassTheMSRA #MSRAOnlineRevision

🎧MSRA PODCAST:Pancreatic Cancer – The Silent but Lethal Disease

🩺 Your focused, high-yield revision session onpancreatic cancer. From red flags to real risks, this podcast covers everythingyou need to know for the MSRA – fast, clear, and clinically relevant.

🧠Key Learning Points

📌Definition

• Malignancy of thepancreas, most commonly pancreatic ductaladenocarcinoma

• Arises most oftenin the head of the pancreas

🧠95% of pancreaticcancers = adenocarcinoma

📌Causes & RiskFactors

✔️Smoking

✔️Chronic pancreatitis

✔️Obesity

✔️Family history

✔️Age >65

✔️Diabetes

✔️Genetic mutations: BRCA2, Lynch syndrome, Peutz-Jeghers

🧠Mnemonic: SAFE CODR – Smoking, Age,Family history, Endocrine (Diabetes), Chronic pancreatitis, Obesity, Diet (redmeat), Rare syndromes

📌Pathophysiology

• Mutations inpancreatic duct cells → loss of regulation → uncontrolledgrowth

• Early local invasion and metastasis: liver,peritoneum, lungs

🧠Silent early,aggressive later

📌DifferentialDiagnosis

Think of other causes of upper abdominal pain or jaundice:

• Gallstones, pepticulcers, hepatitis

•Cholangiocarcinoma, common bile duct stones

• Other GI orhepatobiliary cancers

🧠Mnemonic forpainless jaundice DDx: BCPC – Bile duct stricture, Common duct stone, Pancreatitis,Cholangiocarcinoma

📌Epidemiology

• 11th most common cancer in the UK

• 5th leading cause of cancer death

• <20% diagnosed when curable

• <5% 5-year survival rate

🧠Late diagnosis +early spread = poor prognosis

📌Clinical Features

⚠️Classic triad:

 1. Abdominal pain (epigastric → radiates to back)

 2. Painless jaundice

 3. Weight loss

✔️ Other signs: Dark urine, pale stools,steatorrhoea, anorexia, new-onset diabetes

✔️ Rare signs: Courvoisier’s sign (palpablegallbladder), Virchow’s node, Trusseau’s sign (migratory thrombophlebitis)

🧠Mnemonic: AJP + AUS – Abdo pain,Jaundice, Pancreatitis + Anorexia, Unexplained weight loss, Steatorrhoea

📌Diagnosis &Investigations

✅CT pancreas protocol – first-line imaging

✅EUS with biopsy – high sensitivity

✅MRI/MRCP – for ducts & cysts

✅Bloods: LFTs (↑ALP, ↑bilirubin), glucose, CA 19-9 (monitoring only)

🧠Mnemonic: CUEM + BLT – CT, US, EUS,MRCP + Bloods, LFTs, Tumour markers

📌Staging & Grading

• TNM staging – Tumour size, lymph nodes,metastasis

• Grading – how abnormal the tumour cells look

🧠T1–T4, N0–N1, M0–M1

📌Management

✔️Surgery (Whipple’sprocedure) – only chance of cure

✔️Adjuvant chemotherapy – Gemcitabine + Capecitabine

✔️FOLFIRINOX – for fit metastatic cases

✔️Palliative care – essential for quality of life

🧠Multidisciplinaryspecialist care is key

📌Complications

🚨ODI mnemonic

 – Obstruction: Bile duct or duodenum

 – DVT/PE: Hypercoagulability

 – Intractable pain: Nerve involvement,inflammation

🧠Think ODI =Obstruction, DVT/PE, Intractable pain

📌Prognosis &Prevention

• 5-year survival ~7% in the UK

• Risk reduction:

 – Stop smoking

 – Healthy BMI

 – High fruit/vegdiet

• Surveillance: High-risk patients only (e.g.,BRCA1/2, Peutz-Jeghers)

📎Pancreatic CancerMSRA Resources

📝Revision Notes:

https://www.passthemsra.com/topic/pancreatic-cancer-revision-notes/

🧠Flashcards:

https://www.passthemsra.com/topic/pancreatic-cancer-flashcards/

💬Accordion Q&ANotes:

https://www.passthemsra.com/topic/pancreatic-cancer-accordion-qa-notes/

🚀Rapid Fire Quiz:

https://www.passthemsra.com/topic/pancreatic-cancer-rapid-quiz/

🎓Gastro Course Home:

https://www.passthemsra.com/courses/gastroenterology-for-the-msra/

Hashtags

#MSRA#PancreaticCancer #GastroMSRA #MSRAFlashcards #MSRARevision #NICEGuidelines#WhippleProcedure #FOLFIRINOX #PainlessJaundice #CA199 #MSRAQuiz#MultiSpecialtyRecruitmentAssessment

⚕️ FREE MSRA PODCAST – Oesophageal Varices
🎧 High-yield, focused revision of oesophageal varices – causes, symptoms, investigations, and emergency management. Essential for MSRA gastro + acute care prep.

🧠 Key Learning Points

📌 Definition
• Dilated submucosal veins in the lower oesophagus
• Most often a complication of portal hypertension due to cirrhosis

📌 Causes
• Portal hypertension – main cause
– Cirrhosis (alcohol, hepatitis B/C, NAFLD)
• Pre-hepatic: portal/splenic vein thrombosis
• Intra-hepatic: idiopathic, alcoholic hepatitis
• Post-hepatic: Budd-Chiari, RHF
• Global: Schistosomiasis (non-cirrhotic)

📌 Pathophysiology
• ↑ Portal pressure → diversion via portosystemic collaterals
• Veins in lower oesophagus distend → prone to rupture
• Risk ↑ when HVPG >10–12 mmHg

📌 Epidemiology
• 10% of upper GI bleeds
• 8% of cirrhotic patients develop varices
• High mortality with acute bleeds in advanced liver disease

📌 Symptoms & Signs
• Often silent until bleeding
• Classic: Haematemesis, melena
• Severe: shock (hypotension, tachycardia), confusion (encephalopathy)
• Liver disease stigmata: jaundice, ascites, spider naevi, asterixis

📌 Diagnosis
• Bloods: FBC, U&Es, LFTs, INR, Group & Save
• OGD = gold standard
• Supportive: chest X-ray, ultrasound, paracentesis if SBP suspected

📌 Emergency Management
🔴 Resuscitation (ABCDE):
– Secure airway, oxygen, fluids/blood, monitor vitals

💊 Medical:
– Terlipressin IV
– IV antibiotics (e.g. ceftriaxone)
– PPI infusion
– Vitamin K, FFP if coagulopathic

📍 Endoscopy (within 24h):
– Band ligation (first-line)
– Glue injection for gastric varices

🛑 If bleeding persists:
– Balloon tamponade (e.g. Sengstaken-Blakemore tube)
– TIPSS (shunt) for uncontrolled bleeding

📌 Prevention
• Primary prophylaxis:
– Non-selective beta-blockers (propranolol, carvedilol)
– Band ligation if intolerant
• Secondary prophylaxis:
– Beta-blockers + repeat banding until eradication
– Routine surveillance OGD in cirrhotics

📌 Complications
• Hypovolaemic shock, death
• Rebleeding: up to 70% within 2 years
• Hepatic encephalopathy
• SBP, pneumonia
• Poor prognosis in Child-Pugh C cirrhosis

📎 More MSRA Resources for Oesophageal Varices

📝 Revision Notes: https://www.passthemsra.com/topic/oesophageal-varices-revision-notes/

🧠 Flashcards: https://www.passthemsra.com/topic/oesophageal-varices-flashcards/

💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/oesophageal-varices-accordion-qa-notes/

🚀 Rapid Quiz: https://www.passthemsra.com/topic/oesophageal-varices-rapid-quiz/

🎓 Full Course: https://www.passthemsra.com/courses/gastroenterology-for-the-msra/

#MSRA #MSRARevisionNotes #MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards#MSRAQ&ANotes #MSRAAccordions #MultiSpecialityRecruitmentAssessment#MSRAOnlineRevision #MSRARevisionWebsite #OesophagealVarices

⚕️ FREE MSRA PODCAST – Oesophageal Cancer
🎧 A high-yield breakdown of this aggressive upper GI malignancy. Perfect for exam prep and clinical scenarios.

🧠 Key Learning Points

📌 Definition
• Malignant tumour of the oesophageal lining.
• SCC – upper/mid-oesophagus; AC – lower oesophagus (Barrett’s-related).

📌 Causes & Risk Factors
• SCC: Smoking, alcohol
• AC: GORD → Barrett’s
• Others: Obesity, low fruit/veg diet, nitrosamines, genetics, hiatal hernia
• Rare: Plummer–Vinson, ptilosis, poor dental hygiene, H. pylori
Mnemonic:
– S for Squamous → Smoking, Spirits
– A for Adeno → Acid, AC, Barrett’s

📌 Pathophysiology
• Chronic inflammation → mutations → dysplasia → malignancy
• SCC: squamous cells; AC: glandular metaplasia (Barrett’s)
• Invasion + metastatic potential

📌 Symptoms
• Progressive dysphagia, weight loss
• Regurgitation, chest pain, hoarseness, persistent cough
• Advanced: odynophagia, melena, anorexia
Red Flags: Dysphagia, anaemia, chest pain, voice change, GI bleeding

📌 Differential Diagnosis
• Oesophageal stricture, achalasia, GORD
• Gastric/bronchial cancer, lymphadenopathy, benign lesions

📌 Diagnosis
• Gold standard: Upper GI endoscopy + biopsy
• Staging:
– EUS (tumour depth)
– CT TAP
– PET-CT (occult spread)
– Laparoscopy (junctional tumours)
• Bloods: FBC, U&E, LFTs, CRP, glucose
• HER2 testing (targeted therapy planning)

📌 Management
1. Early (T1N0):
• EMR or surgical resection (Ivor Lewis)
2. Localised (T2/T3 N+):
• Neoadjuvant chemo/chemoradiotherapy → surgery → adjuvant chemo
3. Advanced SCC / Unresectable:
• Radical chemoradiotherapy, palliative care
4. Metastatic / Palliative:
• Symptom control (e.g. radiotherapy, stents)
• Nutrition: PEG/NJ tube
• HER2+? → Trastuzumab

Important procedures:
• Bronchoscopy (if hoarseness/high tumour)
• FNA of palpable neck nodes
• Feeding support

📌 Complications
• Obstruction, bleeding, perforation
• Fistulae (e.g. tracheo-oesophageal)
• Metastases (liver, lungs, bone)
• Treatment risks: chemo side effects, leaks, infections
• Social + psychological impact

📌 Prognosis
• 5-year survival ~20–25% overall
• Better if early-stage and fit for surgery
• Late-stage = poor prognosis
• HER2+, nodal spread → worse outcome

📌 Prevention & Screening
• Stop smoking/alcohol, manage GORD/obesity
• Barrett’s surveillance if high risk
• No general screening currently recommended

📎More MSRA Resourcesfor Oesophageal Cancer

📝 Revision Notes:

https://www.passthemsra.com/topic/oesophageal-cancer-revision-notes/

🧠 Flashcards:

https://www.passthemsra.com/topic/oesophageal-cancer-flashcards/

💬 Accordion Q&A Notes:

https://www.passthemsra.com/topic/oesophageal-cancer-accordion-qa-notes-2/

🚀 Rapid Quiz:

https://www.passthemsra.com/topic/oesophageal-cancer-rapid-quiz-2/

🎓 Full Course:

https://www.passthemsra.com/courses/gastroenterology-for-the-msra/

#MSRA #MSRARevision#MSRATextbook #MSRAQuiz #MSRAQuestionBank #MSRAFlashcards #MSRAQandANotes#MSRAAccordions #MultiSpecialityRecruitmentAssessment #MSRAOnlineRevision#MSRARevisionWebsite #OesophagealCancer

⚕️ FREE MSRA PODCAST – Mallory-Weiss Syndrome
🎧 High-yield breakdown of this mucosal tear caused by vomiting/retching – perfect for MSRA prep and clinical practice.

🧠 Key Learning Points

📌 Definition
• MWS = longitudinal mucosal lacerations at the gastro-oesophageal junction
• Triggered by forceful vomiting or retching
• First described in alcohol-associated cases (1929)

📌 Causes & Risk Factors
• Vomiting, retching, dry heaving
• Alcohol misuse, bulimia, gastroenteritis
• Hyperemesis gravidarum (pregnancy)
• Coughing, hiccups, straining
• Hiatal hernia, renal disease, migraines, hepatitis
• Medications: NSAIDs, chemo
• Rare: trauma, CPR, endoscopy
• Idiopathic cases exist

💡 Mnemonic – “Got BEER So Very Rough”
Gastroenteritis, Bulimia, Excess alcohol, Emesis, Renal disease, Severe vomiting, ↑ICP, Rough coughing

📌 Pathophysiology
• Sudden pressure increase (e.g. vomiting) → mucosal tears
• Occurs at gastro-oesophageal junction
• Typically partial-thickness tears (mucosa/submucosa)

📌 Symptoms
• Classic: Haematemesis after vomiting
• Melena if slow bleed
• Dizziness, syncope if blood loss severe
• May have epigastric discomfort

📌 Differential Diagnosis
• Peptic ulcer, varices, gastritis, Boerhaave’s, GI malignancy

💡 Mnemonic – “PUB GOES BAD”
Peptic ulcer, Upper GI bleed, Boerhaave’s, Gastritis, Oesophageal varices, Stomach cancer, Benign lesions, AV malformation, Duodenal ulcer

📌 Diagnosis
• Gold standard: Upper GI endoscopy
• Bloods:
– FBC (Hb)
– U&Es, creatinine
– Coag screen
– Group & Save / crossmatch

💡 Mnemonic – “Funky Cats Really Eat Apples”
FBC, Coag, Renal, Electrolytes, Antibody screen

📌 Management
• Initial resus: ABCs, O₂, IV access, fluids/blood, correct coagulopathy
• Endoscopy within 24h:
– Diagnostic + therapeutic (clips, adrenaline, coagulation)
– Avoid PPI pre-endoscopy
• Risk assessment:
– Rockall / Glasgow-Blatchford Score
– Rebleeding highest within 48h

📌 Complications
• Rebleeding (esp. with cirrhosis, renal disease)
• Aspiration pneumonia
• Rare: perforation, mediastinitis
• Procedure-related complications

📌 Prognosis
• Excellent: most stop bleeding spontaneously
• 5–15% rebleed within 48h
• Mortality ~7–14%, mainly from comorbidities

📌 Prevention
• Address vomiting triggers (e.g. alcohol, infections)
• Manage reflux, chronic cough
• PPIs for prevention in high-risk cases
• Avoid NSAIDs where possible

💡 Mnemonic – “Tears After Cheers”
Easy recall for vomiting + alcohol = mucosal tears

📎More MSRA Resourcesfor Mallory-Weiss Syndrome

📝 Revision Notes: https://www.passthemsra.com/topic/mallory-weiss-syndrome-revision-notes/

🧠 Flashcards: https://www.passthemsra.com/topic/mallory-weiss-syndrome-flashcards/

💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/mallory-weiss-syndrome-accordion-qa-notes/

🚀 Rapid Quiz: https://www.passthemsra.com/topic/mallory-weiss-syndrome-rapid-quiz/

🎓 Full Course: https://www.passthemsra.com/courses/gastroenterology-for-the-msra/

Hashtags

#MSRA #MSRARevision#MalloryWeissSyndromeMSRA #MSRAFlashcards #GastroenterologyMSRA #NICEGuidelines#MSRAExam #MSRAStudyMaterials #MedicalEducation #MSRAOnlineRevision#MultiSpecialityRecruitmentAssessment

🎧 FREE MSRA PODCAST – Irritable Bowel Syndrome (IBS): Diagnosis, Triggers & Management
Your ultimate high-yield guide to IBS, ideal for MSRA revision. Clear, concise, practical.

🧠 Key Learning Points

📌 Definition
• IBS is a functional gastrointestinal disorder—no visible pathology, characterised by abdominal pain linked with altered bowel habits (diarrhoea, constipation, or mixed).
• Now understood as a disorder of brain–gut interaction.

📌 Causes & Risk Factors
• Multifactorial—no single cause.
• Key factors: abnormal gut motility, visceral hypersensitivity, brain–gut dysfunction, post-infectious triggers, psychological stress, gut microbiome imbalance, genetics.
• Risk factors: female sex, age <50, previous GI infections, family history, anxiety or depression.

📌 Mnemonics
CIA – Core Investigations:
• Coeliac screen
• Inflammatory markers (CRP, ESR, faecal calprotectin)
• Anaemia check (FBC)

T-REF – Not routinely needed:
• Thyroid tests
• Routine scopes
• Endoscopy
• Faecal occult blood

WEIGHT – Red Flags:
• Weight loss
• Elderly onset
• Intestinal bleeding
• Gut inflammation
• Haemoglobin (anaemia)
• Test abnormalities (high CRP/calprotectin)

FLOW – Referral Reasons:
• Family history (cancer, IBD)
• Loss of weight
• Older than 60 with new symptoms
• Worsening bleeding

SLDP – First-line Management:
• Stress reduction
• Lifestyle (exercise, sleep)
• Dietary changes (fibre, low-FODMAP)
• Probiotics trial

ALAPIER – Medications:
• Antispasmodics
• Laxatives
• Antidepressants (TCAs/SSRIs)
• Pain relief
• IBS-targeted agents (Rifaximin, Linaclotide)
• Emerging treatments
• Rehydration (for diarrhoea)

📌 Clinical Features
• Recurrent abdominal pain related to defecation
• Bloating, distension, altered stool form/frequency
• Mucus in stool; worse with stress/foods
• Extraintestinal: fatigue, nausea, urinary urgency

📌 Diagnosis (Rome IV criteria)
• Abdominal pain ≥1 day/week, last 3 months
• Pain related to defecation, stool frequency/form change
• Exclude IBD, Coeliac, malignancy, infections (Giardia), bile acid malabsorption

📌 Investigations
✅ Do: FBC, CRP/ESR, faecal calprotectin, coeliac serology
🚫 Don’t routinely: Colonoscopy, thyroid tests, ultrasound, FOB, hydrogen breath tests

📌 Management

1. Lifestyle & Diet
   • Regular meals, reduce caffeine/alcohol
   • Trial fibre, low-FODMAP diet (with dietitian)
   • Probiotics (4-week trial)

2. Medications (symptom-based)
   • Diarrhoea: Loperamide
   • Constipation: Laxatives (macrogol, lactulose)
   • Pain/bloating: Antispasmodics (Mebeverine, peppermint oil)
   • Persistent pain: TCAs (amitriptyline), SSRIs

3. Psychological Support
   • CBT, hypnotherapy—if refractory symptoms persist

4. Specialist / Second-Line Treatments
   • IBS-D: Rifaximin
   • IBS-C: Linaclotide, Lubiprostone
   • Rare use: Ondansetron (IBS-D)

📌 Prognosis & Complications
• Chronic, fluctuating symptoms
• No increased cancer/IBD risk
• Significant quality of life impact, mental health
• Slight increased risk of certain surgeries due to hypersensitivity

📎 More MSRA Resources for IBS

📝 Revision Notes:

https://www.passthemsra.com/topic/irritable-bowel-syndrome-revision-notes/

🧠 Flashcards:

https://www.passthemsra.com/topic/irritable-bowel-syndrome-flashcards/

💬 Accordion Q&A Notes:

https://www.passthemsra.com/topic/irritable-bowel-syndrome-accordion-qa-notes/

🚀 Rapid Quiz:

https://www.passthemsra.com/topic/irritable-bowel-syndrome-rapid-quiz/

🎓 Full Course:

https://www.passthemsra.com/courses/gastroenterology-for-the-msra/

Hashtags

#MSRA#MSRARevisionNotes #IrritableBowelSyndrome #MSRAQuiz #MSRAFlashcards#MSRAQandANotes #FunctionalGutDisorders #RomeCriteria #GastroMSRA#NICEGuidelines #MSRAExam #MSRARevisionWebsite

🎧MSRA PODCAST:Non-Alcoholic Fatty Liver Disease (NAFLD) – A Silent Epidemic

🩺 A complete, high-yield review of NAFLD – the mostcommon liver disease in the developed world. From definition to diagnosis,differentials to complications – this is your go-to audio revision for theMSRA.

🧠Key Learning Points

📌Definition

• NAFLD = fat accumulation in the liver withoutsignificant alcohol intake

• A spectrum:

 – Simple steatosis → fat only

 – NASH (Non-Alcoholic Steatohepatitis) → fat +inflammation ± fibrosis

🧠Mnemonic: “NAFLD is fatty liver without the booze”

📌Causes & RiskFactors

• Closely linked to Metabolic Syndrome:

 – Obesity

 – Type 2 diabetes

 – Insulin resistance

 – Hypertension

 – Dyslipidaemia

• Other riskfactors:

 – Rapid weight loss

 – PCOS

 – Certainmedications

 – Older age andgenetic predisposition

🧠Memory aid: OMG = Older age, Metabolic syndrome, Genetics

📌Pathophysiology

• Excess fat (mostlytriglycerides) builds up in hepatocytes

• Driven by insulin resistance, mitochondrial dysfunction,and increased fatty acid delivery to the liver

🧠Too much in, notenough out

📌DifferentialDiagnosis

• Must rule out other liver conditions:

 – Alcoholic liverdisease

 – Viral hepatitis(A, B, C, E)

 – Haemochromatosis,Wilson’s disease

 – Autoimmunehepatitis, PBC, PSC

 – Medications,thyroid disease, alpha-1 antitrypsin deficiency

📌Epidemiology

• UK prevalence ~ 20–30% of adults

• NASH ~ 5% in Europe

• Up to 94% in obese populations

• Leading cause ofabnormal LFTs in developed countries

📌Clinical Features

• Often asymptomatic

• If present:

 – Fatigue

 – Right upperquadrant discomfort

 – Hepatomegaly

• Late complications:

 – Cirrhosis

 – Portalhypertension

 – Hepatocellularcarcinoma (HCC)

🧠ALT ↑ early, but canfall with worsening disease

📌Diagnosis &Investigations

✅LFTs – ALT > AST (early)

✅Ultrasound – bright liver (↑ echogenicity)

✅ELF, FIB-4, NAFLD Fibrosis Score – estimate fibrosis risk

✅Fibroscan – liver stiffness

✅Liver biopsy – gold standard (for NASH/fibrosis staging)

🧠Normal LFTs ≠ normalliver

📌Management

Lifestyle is key:

✔️Weight loss (5–10% of body weight)

✔️Mediterranean diet

✔️Regular exercise

❌ Avoid alcohol

❌ No crash diets

💊 No drugs currently licensed in the UK specificallyfor NASH

🧠Everything hinges onlifestyle modification

📌Complications

• NASH → Fibrosis→ Cirrhosis → Liver cancer

• ↑ risk of Cardiovascular disease (leading cause of deathin NAFLD patients)

🧠Not always harmless– monitor and refer high-risk patients

📎NAFLD MSRA Resources

📝Revision Notes:

https://www.passthemsra.com/topic/non-alcoholic-fatty-liver-disease-revision-notes/

🧠Flashcards:

https://www.passthemsra.com/topic/non-alcoholic-fatty-liver-disease-flashcards/

💬Accordion Q&ANotes:

https://www.passthemsra.com/topic/non-alcoholic-fatty-liver-disease-accordion-qa-notes/

🚀Rapid Fire Quiz:

https://www.passthemsra.com/topic/non-alcoholic-fatty-liver-disease-rapid-quiz/

🎓Gastro Course Home:

https://www.passthemsra.com/courses/gastroenterology-for-the-msra/

Hashtags

#MSRA #NAFLD #NASH#FattyLiver #MetabolicSyndrome #MSRARevision #GastroMSRA #MSRAFlashcards#LiverHealth #MSRAQuiz #NICEGuidelines #MSRAOnlineRevision#NonAlcoholicFattyLiverDisease

🎧 FREE MSRA PODCAST – Hepatorenal Syndrome:

Hepatorenal Syndrome (HRS) is a complex yet vital topic for those managing patients with advanced liver disease or revising for the MSRA.

🧠 Key Learning Points

📌 Definition

• Hepatorenal Syndrome (HRS) is a functional form of acutekidney injury (AKI) seen in patients with advancedliver disease, cirrhosis.

• There is no structural damage to the kidneys – theyappear normal, but fail due to changes in circulatorydynamics caused by liver failure.

📌 Causes / Risk Factors

• Cirrhosis with portal hypertension

• Spontaneous bacterial peritonitis (SBP) or other infections

• Gastrointestinal bleeding

• Overuse of diuretics

• Alcoholic hepatitis

📌 Mnemonics

• Type 1 = Terrible & Timely Decline (rapid, severe, high mortality)

• Type 2 = Two steps slower (gradual decline, still serious)

• Diagnosis Tip: "Exclusion + Albumin Test + No nephrotoxins = HRS"

• Pathophysiology Anchor: Splenic vasodilation → RAAS/SNS activation → Renal vasoconstriction → ↓ renal perfusion

📌 Pathophysiology

• Cirrhosis → splenic arterial vasodilation → ↓ systemicvascular resistance

• Compensatory mechanisms: RAAS + Sympathetic activation → renal vasoconstriction

• Results in severe drop in renal perfusion

• Despite kidneys being structurally normal, functiondeteriorates due to altered blood flow

📌 Types

• Type 1: Rapid progression (creatinine doublesin <2 weeks), poor prognosis

• Type 2: Slower progression, more stable butstill poor outlook

📌 Differential Diagnosis

Rule out:

• Pre-renal AKI (e.g., dehydration) • Acute tubular necrosis (ATN) • Intrinsic renal disease (e.g., glomerulonephritis)

• Obstructive uropathy (e.g., stones, strictures)

📌 Diagnosis

Based on diagnostic criteria:

• Cirrhosis with ascites

• AKI with no improvement after 2 days of stopping diuretics and giving IV albumin

• No shock, no nephrotoxins, and no structural kidneydisease

• Normal renal imaging, no proteinuria or hematuria

→ Diagnosis of exclusion

📌 Symptoms

• Oliguria (low urine output)

• Worsening ascites and peripheral oedema

• Fatigue, worsening jaundice

• Often overlaps with signs of decompensated liver disease

📌 Management

1. Medical Treatment

• Terlipressin + IV albumin = gold standard

• Alternatives: Noradrenaline, Midodrine + Octreotide

• Stop nephrotoxins, diuretics, and treat infections (e.g., SBP)

2. Transjugular Intrahepatic Portosystemic Shunt (TIPS)

• Can help in select patients with portal hypertension

• Risky in severe liver failure

3. Liver Transplant • Only definitive cure • Combined liver-kidney transplant may be needed if dialysis >3 months

4. Dialysis • Supportive bridge to transplant or recovery

• Doesn’t improve long-term survival on its own

📌 Prognosis

• Poor without transplant • Type 1: Median survival may be <2 weeks • Type 2: Slightly better, but still poor • Transplant improves 5-year survival up to 60%

📌 Complications

• Progressive kidney failure • Infections – sepsis, SBP, pneumonia • GI bleeding • Type 2 can become Type 1

📌 Prevention

• Albumin infusion in SBP to reduce HRS risk

• Manage liver disease proactively

• Stop nephrotoxic drugs

• Consider Norfloxacin prophylaxis in some patients

📎 More MSRA Resources for Hepatorenal Syndrome

📝 Revision Notes: https://www.passthemsra.com/topic/hepatorenal-syndrome-revision-notes/

🧠 Flashcards: https://www.passthemsra.com/topic/hepatorenal-syndrome-flashcards/

💬 Accordion Q&A Notes: https://www.passthemsra.com/topic/hepatorenal-syndrome-accordion-qa-notes/

🚀 Rapid Quiz: https://www.passthemsra.com/topic/hepatorenal-syndrome-rapid-quiz/

🎓 Full Course: https://www.passthemsra.com/courses/gastroenterology-for-the-msra/

#MSRA #MSRARevisionNotes #HepatorenalSyndrome #LiverFailure #CirrhosisComplications#MSRAFlashcards #MSRAQandANotes #MSRAQuiz #GastroenterologyMSRA #NICEGuidelines#MedicalEducation MultiSpecialityRecruitmentAssessment